Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alignment Healthcare, Inc. (NASDAQ: ALHC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Medicare Advantage-focused health insurer. Alignment files annual and quarterly reports, along with current reports on Form 8-K, that describe its financial condition, operations and key developments in its Medicare Advantage business.
Recent Form 8-K filings show that Alignment uses these reports to announce quarterly financial results and share information discussed with investors and analysts. For example, the company has filed 8-Ks to furnish press releases on second and third quarter results and to outline discussions of strategy, market position and preliminary CMS Star Ratings. These filings often reference non-GAAP measures such as adjusted gross profit and adjusted EBITDA, which are defined and reconciled to the most comparable GAAP measures in accompanying tables.
Alignment’s SEC filings also provide detail on revenue sources and expenses. Condensed consolidated statements of operations list earned premiums and other revenue, along with medical expenses, selling, general and administrative expenses, and depreciation and amortization. Balance sheet information includes medical expenses payable, long-term debt and stockholders’ equity, giving investors a structured view of the company’s capital and obligations.
Through this page, users can track ongoing 8-K disclosures related to earnings releases, guidance updates, investor presentations and other material events. Filings may also reference CMS Star Ratings, membership expectations and risk factors summarized in the company’s Form 10-K and other periodic reports. Stock Titan enhances access to these documents with AI-powered tools that help explain terminology, highlight key sections and summarize lengthy filings, allowing investors to more quickly understand how ALHC reports its performance, membership trends and risk profile.
Alignment Healthcare, Inc. President Dawn Christine Maroney reported a mandatory sale of 36,749 shares of common stock. The shares were sold in open-market transactions at a weighted-average price of $17.84 per share to cover tax withholding obligations from vesting restricted stock units, and are described as non-discretionary. Following these transactions, Maroney directly holds 1,058,813 shares of Alignment Healthcare common stock. Individual sales occurred at prices ranging from $17.40 to $18.24 per share.
Alignment Healthcare, Inc. Chief Executive Officer John E. Kao reported an open-market sale of 73,046 shares of common stock at a weighted-average price of $17.84 per share. According to the disclosure, these shares were sold to cover tax withholding obligations arising from vesting of restricted stock units and did not represent a discretionary trade.
After the sale, Kao directly owned 1,784,868 common shares. He also had an additional 2,472,641 shares held indirectly through the JEK Trust dated February 8, 2021, for which he serves as trustee.
Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported an open-market sale of 11,285 shares of common stock. The shares were sold primarily to cover tax withholding obligations tied to the vesting of restricted stock units, so the transaction was not a discretionary trade. The weighted-average sale price was $17.84 per share, with individual trades ranging from $17.40 to $18.24. After this tax-related sale, Scavo holds 487,685 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported open-market sales of Alignment Healthcare common stock primarily to cover tax withholding from vesting restricted stock units. He sold 12,000 shares on March 18, 2026 at a weighted-average price of $17.84 per share and 11,602 shares on March 19, 2026 at a weighted-average price of $18.2207 per share.
The filing states these sales were required to satisfy tax obligations and "do not represent a discretionary trade" by Wagner, and were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025. After these transactions, he directly holds 148,628 shares of Alignment Healthcare common stock.
ALHC notice reports proposed resale activity by Andreas P. Wagner under 10b5-1 plans. The filing lists two common-stock sale entries: 21,118 shares on 03/04/2026 for $393,251.97 and 22,238 shares on 02/10/2026 for $455,211.86. Broker information shows Morgan Stanley Smith Barney LLC as executing broker.
Wagner Andreas P. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner received an equity grant in the form of restricted stock units. The award covers 23,543 units, each representing one share of common stock. These units vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service with the company. Following this grant, Wagner directly holds 172,230 shares of Alignment Healthcare common stock, reflecting both existing ownership and the new award.
Burzacchi Sebastian reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that COO - Mgmt Services Org Sebastian Burzacchi received a grant of 36,198 shares of Common Stock in the form of restricted stock units. These units carry no purchase price and increase his direct holdings to 273,991 shares after the award.
According to the terms, the 36,198 restricted stock units will vest in three approximately equal installments on each of the first three anniversaries of the grant date, as long as Burzacchi continues to provide service to the company on each vesting date. This is a compensation-related equity award rather than an open‑market share purchase.
Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare reported that Chief Digital Officer Adnan R. Mansour received a grant of 25,015 restricted stock units of Common Stock on March 13, 2026. These RSUs vest in roughly one-third increments on each of the first three anniversaries of the grant date, if he continues serving the company. After this award, he directly holds 48,456 shares or units tied to Alignment Healthcare stock. This transaction reflects equity-based compensation rather than an open-market purchase.
JOYCE CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Legal and Administrative Officer Christopher J. Joyce received an equity grant of 51,501 shares of Common Stock in the form of restricted stock units. These units were awarded at no cash cost per share as part of his compensation.
The 51,501 restricted stock units will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, as long as he continues serving the company through each vesting date. After this grant, he directly holds 348,589 shares of the company’s Common Stock.
Kim Hyong reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Medical Officer Hyong Kim received an equity grant of 52,972 shares of Common Stock in the form of restricted stock units at no cash cost. These units vest in roughly equal thirds on each of the first three anniversaries of the grant date, contingent on continued service. Following this grant, Kim holds 386,105 shares directly, underscoring this as a routine, compensation-related award rather than an open-market purchase.